SCHEMBL6174264

SCHEMBL6174264

CC(c1cc(F)nc2ccccc12)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.43
LMNA P02545 3/20 0.39
AR P10275 1/20 0.35
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 2/20 0.31
MEN1 O00255 1/20 0.31
S1PR4 O95977 1/20 0.31
MAPT P10636 1/20 0.31
XBP1 P17861 1/20 0.31
S1PR1 P21453 1/20 0.31
MC4R P32245 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALDH1A1 P00352 1/20 0.30
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173087 0.89 IGF1R (0.41) IGF1RLMNAARCYP3A4CYP2D6
SCHEMBL6172527 0.86 KDM4E (0.41) IGF1RLMNAARHTTMAPT
SCHEMBL6175754 0.84 LMNA (0.39) IGF1RLMNAAR
SCHEMBL6171156 0.79 IGF1R (0.47) IGF1RLMNAHTTMAPK1SMN1; SMN2
SCHEMBL6174189 0.78 IGF1R (0.42) IGF1RLMNAHTTNPSR1ALDH1A1
SCHEMBL6176730 0.78 IGF1R (0.46) IGF1RLMNASMN1; SMN2
SCHEMBL6173669 0.78 IGF1R (0.46) IGF1RLMNA
SCHEMBL6175238 0.76 IGF1R (0.43) IGF1RLMNAHTTMEN1KMT2A
SCHEMBL6172371 0.76 IGF1R (0.45) IGF1RLMNAHTTMAPK1SMN1; SMN2
SCHEMBL6175297 0.76 LMNA (0.39) IGF1RLMNAARCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed